A detailed history of Huntington National Bank transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Huntington National Bank holds 470 shares of MEDP stock, worth $163,513. This represents 0.0% of its overall portfolio holdings.

Number of Shares
470
Previous 445 5.62%
Holding current value
$163,513
Previous $183,000 14.75%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$320.58 - $457.29 $8,014 - $11,432
25 Added 5.62%
470 $156,000
Q2 2024

Aug 08, 2024

BUY
$372.0 - $424.34 $28,272 - $32,249
76 Added 20.6%
445 $183,000
Q1 2024

May 03, 2024

SELL
$284.87 - $413.31 $21,365 - $30,998
-75 Reduced 16.89%
369 $149,000
Q4 2023

Feb 07, 2024

BUY
$227.52 - $312.68 $14,106 - $19,386
62 Added 16.23%
444 $136,000
Q3 2023

Nov 08, 2023

SELL
$233.98 - $281.67 $12,400 - $14,928
-53 Reduced 12.18%
382 $92,000
Q2 2023

Aug 11, 2023

BUY
$187.26 - $240.17 $23,782 - $30,501
127 Added 41.23%
435 $104,000
Q1 2023

May 10, 2023

SELL
$174.31 - $239.52 $2,440 - $3,353
-14 Reduced 4.35%
308 $57,000
Q4 2022

Feb 09, 2023

SELL
$153.06 - $226.57 $40,101 - $59,361
-262 Reduced 44.86%
322 $68,000
Q3 2022

Nov 07, 2022

BUY
$145.13 - $182.49 $45,715 - $57,484
315 Added 117.1%
584 $92,000
Q2 2022

Aug 09, 2022

BUY
$130.2 - $168.03 $19,269 - $24,868
148 Added 122.31%
269 $40,000
Q1 2022

May 10, 2022

BUY
$138.87 - $214.31 $13,748 - $21,216
99 Added 450.0%
121 $20,000
Q4 2021

Jan 21, 2022

BUY
$182.74 - $227.9 $4,020 - $5,013
22 New
22 $5,000
Q1 2021

Apr 12, 2021

SELL
$132.02 - $168.26 $26,932 - $34,325
-204 Closed
0 $0
Q4 2020

Jan 11, 2021

SELL
$109.38 - $149.19 $109 - $149
-1 Reduced 0.49%
204 $28,000
Q2 2020

Jul 30, 2020

SELL
$68.08 - $95.68 $204 - $287
-3 Reduced 1.44%
205 $19,000
Q1 2020

Apr 27, 2020

BUY
$61.71 - $101.95 $12,835 - $21,205
208 New
208 $15,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.8B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Huntington National Bank Portfolio

Follow Huntington National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Huntington National Bank with notifications on news.